Project Grant HT94252510512
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Awardee
Neurocreis, Inc. (XXQPK6Y2QZX6)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
College Station, TX, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $746,972.00 to Texas A&M University to conduct research on "PROTECTING THE INJURED SPINAL CORD: MODULATING AUTONOMIC FUNCTION AFTER SPINAL CORD INJURY (SCI) TO REDUCE TISSUE LOSS AND IMPROVE NEUROLOGICAL OUTCOME". The research seeks to develop new treatments to improve outcomes for individuals with spinal cord injuries by investigating...
The U.S. Defense Health Agency awarded a $963,110 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Regents of the University of California, San Francisco (UCSF) to conduct research on the "Safety of Transcutaneous Electrical Stimulation Potentiating Recovery in Acute Spinal Cord Injury Syndromes (STEP-RAISE)" project. The grant, with a performance period from July 1, 2025 to June 30, 2028, will support UCSF's biomedical research focused...
The Defense Health Agency awarded a $3,977,103 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Washington University to conduct a 4-year clinical trial on nerve transfer surgeries to improve upper limb function and quality of life for patients with high-level cervical spinal cord injuries. The study aims to address critical information gaps on the use of nerve transfer procedures in this patient population. The project will be executed through a...
The U.S. Defense Health Agency awarded a $792,500.00 Project Grant to Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University-Of The Commonwealth System Of Higher Educa and doing business as Temple University, for the purpose of "AN EFFECTIVE STRATEGY TO PROMOTE AXON REGENERATION AND FUNCTIONAL RECOVERY AFTER SPINAL CORD INJURY". The Project Grant is funded through the U.S. Military Medical Research and Development program (CFDA 12.420),...
This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,336 project grant to The Trustees of the Stevens Institute of Technology on March 1, 2024. The grant will support research and development of "BIOACTIVE NERVE GRAFTS FOR PERIPHERAL NERVE REGENERATION" over a 4-year period ending February 29, 2028. As a sub-award under this project, the University of Connecticut Health Center (UCHC) will also conduct research related to this...
This federal Project Grant award, worth $2,966,875.00, was made by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a prospective clinical trial to investigate the optimal timing of surgical decompression for patients with acute spinal cord injuries. The grant recipient, the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, will conduct the research at its facility in Torrance, California over a...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
This Project Grant award of $1,184,252 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program will fund the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The award, with a performance period from September 1, 2025 to August 31, 2028, will be executed by the Centre Hospitalier Universitaire Vaudois (Chuv), a non-profit hospital and research institution based in...